ALISON MOY: Open Payments
NPI 1467024687 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,891 in 93 payments from 20 companies in 2025. Trend: 2023 $99 · 2024 $1,331 · 2025 $1,891
Food & beverage: $1,891
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $442 |
| Novartis Pharmaceuticals Corporation | 13 | $228 |
| Galderma Laboratories, L.P. | 11 | $200 |
| Lilly USA, LLC | 10 | $152 |
| UCB, Inc. | 5 | $135 |
| Incyte Corporation | 5 | $132 |
| Janssen Biotech, Inc. | 4 | $90 |
| GENZYME CORPORATION | 2 | $78 |
| Arcutis Biotherapeutics, Inc. | 3 | $57 |
| Smith+Nephew, Inc. | 1 | $57 |
Products named: SKYRIZI, RINVOQ, NEMLUVIO, TALTZ, COSENTYX, Bimzelx, OPZELURA, DUPIXENT.
Industry payments across NY — which companies pay providers there.
